`
`Subject:
`
`IPR2015-00410: Request for a Conference Call With the Board
`
`From: Vignone, Maria [mailto:Maria.Vignone@USPTO.GOV] On Behalf Of Trials
`Sent: Wednesday, May 06, 2015 4:14 PM
`To: Peter Armenio; Trials
`Cc: Bateman, John; Shen, Karen; Evangeline Shih; Poche, Thomas
`Subject: RE: IPR2015-00410: Request for a Conference Call With the Board
`
`Counsel:
`
`The parties are authorized to file a joint motion to terminate the proceedings in each case, along with a copy of the
`settlement agreement and a separate request that the settlement agreement be treated as business confidential
`information and be kept separate from the case files under 37 C.F.R. 42.74(c). For guidance on what the joint motion to
`terminate must include, we direct the parties to case IPR2015-00293, Paper 7 (PTAB Jan. 8, 2015).
`
`The papers shall be filed no later than Wednesday, May 20.
`
`
`In light of the foregoing, the deadline for Petitioner’s supplemental brief regarding the real party-in-interest issue, which
`is currently due May 7, 2015, is suspended until further notice.
`
`Thank you,
`
`Maria Vignone
`Paralegal Operations Manager
`Patent Trial and Appeal Board
`571-272-4645
`
`
`
`From: Peter Armenio [mailto:peterarmenio@quinnemanuel.com]
`Sent: Wednesday, May 06, 2015 12:25 PM
`To: Trials
`Cc: Bateman, John; Shen, Karen; Evangeline Shih; Poche, Thomas
`Subject: IPR2015-00410: Request for a Conference Call With the Board
`
`To Whom It May Concern:
`
`
`Patent Owner in IPR2015-00410 respectfully requests a conference call with the Board to request leave to file a joint
`motion to terminate the proceedings. The reason for the requested leave to file a joint motion to terminate is that the
`parties have entered into a confidential settlement agreement. Petitioners do not oppose this request.
`
`During the same conference call, Petitioners would also like to request that the Board hold in abeyance the deadline
`(which is currently May 7, 2015) for Petitioners’ supplemental brief and evidence on the real party in interest issue
`(which was authorized by the Board’s April 16, 2015 Order (Paper No. 17)) until after the Board decides all issues relating
`to the proposed joint motion to terminate. Patent Owner does not oppose this request.
`
`Counsel for the parties are available for the requested conference call at the Board’s convenience any time today (May
`6, 2015) and tomorrow (May 7, 2015), and have additional availability should the Board so require. Thank you very
`much.
`
`
`1
`
`Adamas Exhibit 2006
`Ranbaxy Labs. Ltd. et al. (Petitioners) v. Adamas Pharms., Inc. (Patent Owner)
`Case IPR2015-00410
`
`Page 1 of 2
`
`
`
`Respectfully,
`Peter J. Armenio
`Lead Counsel for Patent Owner
`
`
`
`Peter J. Armenio, P.C.
`Quinn Emanuel Urquhart & Sullivan, LLP
`51 Madison Avenue
`New York, NY 10010
`212-849-7070 Direct
`212-849-7100 FAX
`peterarmenio@quinnemanuel.com
`
`NOTICE: The information contained in this e-mail message is intended only for the personal and confidential use of the recipient(s) named above. This message
`may be an attorney-client communication and/or work product and as such is privileged and confidential. If the reader of this message is not the intended
`recipient or agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this document in error and that any
`review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately
`by e-mail, and delete the original message.
`
`
`2
`
`Page 2 of 2